Grimes & Company »

Vertex Pharmaceuticals Incorporated shares owned by Grimes & Company

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Grimes & Company from 13F filings

Historical chart of Grimes & Company investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Grimes & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Grimes & Company

Quarter filed Position value Share count Share price at filing
2024-12-31 $261k 649 402.80
2024-09-30 $293k 630 465.23
2024-06-30 $295k 629 468.67
2024-03-31 $254k 607 417.87
2023-12-31 $207k 509 407.19
2022-03-31 $238k 911 261.25

More positions owned by Grimes & Company

Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Spdr Ser Tr Bloomberg Sht Te (SJNK)
Ishares Tr 0-5yr Hi Yl Cp (SHYG)
Vanguard Index Fds Small Cp Etf (VB)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p500 Etf (IVV)
John Hancock Exchange Traded Mltfctr Lrg Cap (JHML)
Apple (AAPL)
Ishares Tr Russell 2000 Etf (IWM)
Select Sector Spdr Tr Technology (XLK)
Select Sector Spdr Tr Communication (XLC)
Microsoft Corporation (MSFT)
Vaneck Etf Trust High Yld Munietf (HYD)
Spdr Ser Tr Nuveen Bloomberg (HYMB)
Vanguard Index Fds Growth Etf (VUG)

View all positions for Grimes & Company

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
State Street Corporation
Capital Research Global Investors
FMR
Jpmorgan Chase & Co
Wellington Management Company
Geode Capital Management
Jennison Associates
Alliancebernstein
Loomis, Sayles and
Norges Bank Investment Management
Amundi
Morgan Stanley

View all funds holding Vertex Pharmaceuticals Incorporated